ENDRA Life Sciences (NDRA) Cash & Equivalents Growth (5y) (2021 - 2026)
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Cash & Equivalents Growth (5y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.14% |
| Mar 31, 2026 | -53.75% |
| Dec 31, 2025 | -36.23% |
| Sep 30, 2025 | -26.86% |
| Jun 30, 2025 | 19.29% |
| Mar 31, 2025 | -7.82% |
| Dec 31, 2024 | -12.16% |
| Sep 30, 2024 | 15.84% |
| Jun 30, 2024 | 23.07% |
| Mar 31, 2024 | -21.98% |
| Dec 31, 2023 | -15.22% |
| Sep 30, 2023 | 39.24% |
| Jun 30, 2023 | 16.92% |
| Mar 31, 2023 | -5.65% |
| Dec 31, 2022 | -2.69% |
| Sep 30, 2022 | 2.81% |
| Jun 30, 2022 | 8.43% |
| Mar 31, 2022 | 121.50% |
| Dec 31, 2021 | 130.65% |
| Sep 30, 2021 | 174.59% |